 |
||
|---|---|---|
| 【ProductName】 |
BCL7A Antibody Blocking Peptide |
|
| 【Cat NO.】 |
K114674P-Ag |
|
| 【Source】 |
Synthetic |
|
| 【Storage】 |
Store at -20℃，2 years.Avoid freeze/thaw cycles. |
|
| 【Appearance】 |
Lyophilized powder |
|
| 【Swiss Prot】 |
Q4VC05 |
|
| 【Gene ID】 |
605 |
|
| 【Application】 |
Blocking Peptide of K114674P Antibody |
|
| 【Purification】 |
HPLC |
|
| 【Activity】 |
Not tested |
|
| 【Note】 |
Please allow the product to equilibrate to room temperature in a dry environment before opening the packaging. |
|
|
||
Background：
This gene is directly involved， with Myc and IgH， in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation， the N-terminal region of the gene product is disrupted， which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq， Jul 2008]